Search filters

List of works by Yolande Lievens

A systematic methodology review of phase I radiation dose escalation trials

scientific article published on 24 March 2010

A systematic review of health economic evaluation in adjuvant breast radiotherapy: Quality counted by numbers

scientific article published on 15 September 2017

Access to innovative radiotherapy: how to make it happen from an economic perspective?

scientific article

Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction

scientific article

Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?

scientific article published on 23 November 2017

Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical Preference

scientific article published on 02 June 2018

Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients

scientific article published on 14 September 2013

Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology.

scientific article published on 22 July 2015

Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis

scientific article

Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis

scientific article published on December 2016

Cost-effectiveness of particle therapy: current evidence and future needs

scientific article published on 15 August 2008

Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy

scientific article

Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial

scientific article published in November 2002

Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study

scientific article

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression

scientific article

Erratum to "Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?" [Crit. Rev. Oncol. Hematol., 119 (November) (2017) 40-49].

scientific article published on 19 October 2017

Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis.

scientific article published on 29 November 2017

Expanding global access to radiotherapy.

scientific article published on September 2015

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

scientific article published on 9 November 2015

Global impact of radiotherapy in oncology: Saving one million lives by 2035.

scientific article published in November 2017

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey

scientific article published on August 2014

Health Economic Controversy and Cost-Effectiveness of Proton Therapy

scientific article published on April 1, 2013

Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation

scientific article published on 9 December 2014

Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer

scientific article

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis

scientific article

Hypofractionated breast radiotherapy: financial and economic consequences

scientific article published on June 2010

Image of the month. Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer

scientific article published in June 2008

In reply to de Ruysscher et al.

scientific article published in September 2014

In search of the economic sustainability of Hadron therapy: the real cost of setting up and operating a Hadron facility

scientific article published in May 2014

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group

scientific article published on 20 January 2017

Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.

scientific article

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

scientific article published on 17 March 2014

Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.

scientific article published on 23 December 2004

Provision and use of radiotherapy in Europe

scientific article published on 15 April 2020

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

scientific article

Radiotherapy cost-calculation and its impact on capacity planning

scientific article published on August 2003

Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey.

scientific article published in August 2014

Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey

scientific article

Stereotactic body radiotherapy for lung cancer: how much does it really cost?

scientific article published in March 2015

Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.

scientific article

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?

scientific article published on 28 September 2017

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

scientific article published on 12 June 2008

The cost of radiotherapy in a decade of technology evolution

scientific article published on August 26, 2011

The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project.

scientific article

The need for radiotherapy in Europe in 2020: Not only data but also a cancer plan.

scientific article

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis.

scientific article published on 14 May 2015

Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.

scientific article published on 16 March 2005

Value-based health care - what does it mean for radiotherapy?

scientific article published on 05 August 2019